We are live on ! Find out more
GIM

Greylin Investment Management Portfolio holdings

AUM $598M
1-Year Est. Return 18.59%
This Fund
S&P 500
This Quarter Est. Return
-2.67%
1 Year Est. Return
+18.59%
3 Year Est. Return
+52.1%
5 Year Est. Return
+133.23%
10 Year Est. Return
+214.33%
AUM
$598M
AUM Growth
-$25.7M
Cap. Flow
-$887K
Cap. Flow %
-0.15%
Top 10 Hldgs %
71.4%
Holding
85
New
6
Increased
17
Reduced
44
Closed
3

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$2.46M
2
WBA
Walgreens Boots Alliance
WBA
+$2.36M
3
BABA icon
Alibaba
BABA
+$2.31M
4
INTC icon
Intel
INTC
+$1.82M
5
RKT icon
Rocket Companies
RKT
+$1.51M

Top Sells

Rank Stock Value
1
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$4.46M
2
QCOM icon
Qualcomm
QCOM
+$2.47M
3
XOM icon
ExxonMobil
XOM
+$2.04M
4
ALLY icon
Ally Financial
ALLY
+$1.1M
5
MMM icon
3M
MMM
+$1.02M

Sector Composition

Rank Sector Weight
1 Financials 41.72%
2 Energy 14.75%
3 Technology 13.88%
4 Healthcare 12.96%
5 Consumer Staples 4.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GIS icon
76
General Mills
GIS
$20.1B
$228K 0.04%
3,602
+153
+4% +$10.5K
ZBH icon
77
Zimmer Biomet
ZBH
$17.4B
$219K 0.04%
2,020
WSBC icon
78
WesBanco
WSBC
$3.9B
$219K 0.04%
7,845
SWKS icon
79
Skyworks Solutions
SWKS
$8.99B
$210K 0.04%
1,972
-135
-6% -$13.3K
EPD icon
80
Enterprise Products Partners
EPD
$83.9B
$210K 0.04%
7,240
T icon
81
AT&T
T
$153B
$198K 0.03%
10,350
IMMR icon
82
Immersion
IMMR
$213M
$152K 0.03%
+16,205
New +$140K
BMY icon
83
Bristol-Myers Squibb
BMY
$123B
-4,115
Closed -$223K
MPC icon
84
Marathon Petroleum
MPC
$92.1B
-1,000
Closed -$202K
WMB icon
85
Williams Companies
WMB
$90.7B
-6,200
Closed -$242K

Similar funds

Greylin Investment Management's Q2 2024 Portfolio in Review

As of Q2 2024, Greylin Investment Management held 85 positions worth $598M, down 4.1% from $624M the previous quarter. Its ten largest holdings account for 71% of the portfolio.

Greylin Investment Management's Q2 2024 filing shows 6 new, 17 increased, 44 reduced and 3 closed positions. Its largest new stake was Jazz Pharmaceuticals: 9,050 shares worth $966K. The largest sale was Berkshire Hathaway Class B, an estimated $4.46M.

By sector, the portfolio is most concentrated in Financials at 42% of assets, down from 42% a quarter earlier, followed by Energy and Technology.

  • Greylin Investment Management's largest Q2 2024 buy was Jazz Pharmaceuticals: 9,050 shares worth $966K.
  • Greylin Investment Management added most to Pfizer in Q2 2024, an estimated $2.46M increase.
  • Greylin Investment Management's biggest Q2 2024 reduction was Berkshire Hathaway Class B, cutting an estimated $4.46M.
  • Greylin Investment Management fully exited Williams Companies in Q2 2024, selling an estimated $242K.
  • Greylin Investment Management's ten largest holdings make up 71% of its $598M portfolio in Q2 2024.
  • Greylin Investment Management opened 6 new positions and closed 3 in Q2 2024.
  • Greylin Investment Management's portfolio value fell 4.1% quarter-over-quarter to $598M.

Based on Greylin Investment Management's 13F filing for Q2 2024, filed 19 Jul 2024.